Gsa Capital Partners LLP Seres Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.02 - $11.43 $1.2 Million - $2.29 Million
-200,028 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.46 - $22.6 $1.09 Million - $4.52 Million
200,028 New
200,028 $1.39 Million
Q3 2020

Nov 06, 2020
SELL
$3.74 - $28.74 $53,223 - $408,998
-14,231 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$3.04 - $6.2 $43,262 - $88,232
14,231 New
14,231 $68,000

Others Institutions Holding MCRB

# of Institutions
96
Shares Held
46.3M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email